Let’s chat

Building an inhalable future.

About us
SKYX Group is a biotechnology and medical device company headquartered in New York City. Our mission is to create best-in-class aerosol delivery devices for consumer and medical applications.
Kylie Halperin
CEO & Co-Founder
Martin Steinbauer
Chief Engineer & Co-Founder
Frederic Levy
Robert Murtfeld
Director of Policy & Government Relations
Sylvere Azoulai
Chief Creative Officer
Maia Stoicovici
David Hill
Strategic Sales & Principal Advisor

Laurent Manca
Sales & Partnerships EU

Ana Eiriksson

Yasmeen Saleh

SKYX Group is active in the research and development of aerosol delivery systems. The research pipeline includes devices for the inhalable administration of various pharmaceutical active ingredients. Currently, SKYX Group manufactures consumer devices for markets including the United States and the European Union.

For us, it's not just an investment, it's the beginning of a relationship.

No items found.
© 2022 SkyX Group